Point72 Asset Management
SUPN icon

Point72 Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Point72 Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$68.2M Sell
1,318,555
-946,245
-42% -$48.2M 0.09% 269
2025
Q4 		$113M Buy
2,264,800
+503,316
+29% +$24.5M 0.13% 155
2025
Q3 		$84.2M Buy
1,761,484
+1,253,694
+247% +$50.5M 0.14% 152
2025
Q2 		$16M Buy
507,790
+188,887
+59% +$6.05M 0.03% 577
2025
Q1 		$10.4M Buy
318,903
+292,075
+1,089% +$10.3M 0.02% 669
2024
Q4 		$970K Buy
+26,828
New +$945K ﹤0.01% 1465
2024
Q3 		– Sell
-136,342
Closed -$3.65M – 2326
2024
Q2 		$3.65M Buy
136,342
+8,521
+7% +$247K 0.01% 933
2024
Q1 		$4.36M Buy
+127,821
New +$3.81M 0.01% 1007
2023
Q2 		– Sell
-755
Closed -$27.4K – 2760
2023
Q1 		$27.4K Buy
+755
New +$29K ﹤0.01% 1922
2020
Q2 		– Sell
-346,666
Closed -$6.24M – 1009
2020
Q1 		$6.24M Buy
+346,666
New +$7.28M 0.05% 358
2017
Q1 		– Sell
-1,900
Closed -$48K – 952
2016
Q4 		$48K Buy
+1,900
New +$42.5K ﹤0.01% 665
2016
Q3 		– Sell
-35,600
Closed -$725K – 850
2016
Q2 		$725K Sell
35,600
-909,146
-96% -$16.1M ﹤0.01% 646
2016
Q1 		$14.4M Buy
+944,746
New +$12.3M 0.11% 220

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management's SUPN Position: Q1 2026 in Review

Point72 Asset Management reduced its Supernus Pharmaceuticals (SUPN) stake by 42% in Q1 2026, selling an estimated $48.2M and leaving 1,318,555 shares worth $68.2M. The position accounts for 0.09% of the portfolio, ranked #269.

Point72 Asset Management first reported a position in SUPN in Q1 2016 and has held it in 13 quarters since. The position peaked at $113M in Q4 2025. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Point72 Asset Management held 1,318,555 shares of Supernus Pharmaceuticals worth $68.2M as of Q1 2026.
  • Point72 Asset Management sold 946,245 Supernus Pharmaceuticals shares in Q1 2026, an estimated $48.2M.
  • Supernus Pharmaceuticals made up 0.09% of Point72 Asset Management's portfolio in Q1 2026, its #269 holding.
  • Point72 Asset Management first reported a position in Supernus Pharmaceuticals in Q1 2016 and has held it in 13 quarters since.
  • Point72 Asset Management's Supernus Pharmaceuticals position peaked at $113M in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.